Priority Date: 19.07.10 (US 20100365698P)

METHODS OF TREATING METASTATIC BREAST CANCER WITH 4-IODO-3-NITROBENZAMIDE AND IRINOTECAN

  • Application ID: EP11810298
  • Status: APPLICATION WITHDRAWN

Attorney

Company dna adamson jones
no operation time available
987.01
1 office
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Adamson Jones is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 19.07.2010 - Priority Date (US 20100365698P)
  • 26.01.2012 - Publication A1 (WO2012012454)
  • 29.05.2013 - Publication A1 (EP2595619)